Literature DB >> 14769761

The role of transforming growth factor beta in lung development and disease.

Ulrike Bartram1, Christian P Speer.   

Abstract

Transforming growth factor (TGF) beta plays an important role in normal pulmonary morphogenesis and function and in the pathogenesis of lung disease. The effect of TGFbeta is regulated via a selective pathway of TGFbeta synthesis and signaling that involves activation of latent TGFbeta, specific TGFbeta receptors, and intracellular signaling via Smad molecules. All three isoforms of TGFbeta are expressed at high levels during normal lung development, being particularly important for branching morphogenesis and epithelial cell differentiation with maturation of surfactant synthesis. Small amounts of TGFbeta are still present in the adult lung, and TGFbeta is involved in normal tissue repair following lung injury. However, in a variety of forms of pulmonary pathology, the expression of TGFbeta is increased. These include chronic lung disease of prematurity as well as several forms of acute and chronic adult lung disease. While TGFbeta1 appears to be the predominant isoform involved, elevated levels of all three isoforms have been demonstrated. The increase in TGFbeta precedes abnormalities in lung function and detectable lung pathology, but correlates with the severity of the disease. TGFbeta plays a key role in mediating fibrotic tissue remodeling by increasing the production and decreasing the degradation of connective tissue via several mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769761     DOI: 10.1378/chest.125.2.754

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  175 in total

1.  Receptor-activated Smad localisation in bleomycin-induced pulmonary fibrosis.

Authors:  Hiroyuki Higashiyama; Daisuke Yoshimoto; Yuji Okamoto; Hideo Kikkawa; Satoshi Asano; Mine Kinoshita
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

2.  Regulation of surfactant protein and defensin mRNA expression in cultured ovine type II pneumocytes by all-trans retinoic acid and VEGF.

Authors:  B Grubor; D K Meyerholz; T Lazic; M M DeMacedo; R J Derscheid; J M Hostetter; J M Gallup; J C DeMartini; M R Ackermann
Journal:  Int J Exp Pathol       Date:  2006-10       Impact factor: 1.925

3.  IL-10: Another therapeutic target in idiopathic pulmonary fibrosis?

Authors:  A B Millar
Journal:  Thorax       Date:  2006-10       Impact factor: 9.139

4.  Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis.

Authors:  Cecilia Marmai; Rachel E Sutherland; Kevin K Kim; Gregory M Dolganov; Xiaohui Fang; Sophia S Kim; Shuwei Jiang; Jeffery A Golden; Charles W Hoopes; Michael A Matthay; Harold A Chapman; Paul J Wolters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-15       Impact factor: 5.464

5.  Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease.

Authors:  John F Alcorn; Lisa M Rinaldi; Elizabeth F Jaffe; Mirjam van Loon; Jason H T Bates; Yvonne M W Janssen-Heininger; Charles G Irvin
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

6.  Inhibitor of differentiation 1 promotes endothelial survival in a bleomycin model of lung injury in mice.

Authors:  Huimin Zhang; William E Lawson; Vasiliy V Polosukhin; Ambra Pozzi; Timothy S Blackwell; Ying Litingtung; Chin Chiang
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

Review 7.  TGF-β1 Signaling and Tissue Fibrosis.

Authors:  Kevin K Kim; Dean Sheppard; Harold A Chapman
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

8.  Heterochronic regulation of lung development via the Lin28-Let-7 pathway.

Authors:  Nelly Komarovsky Gulman; Leah Armon; Tali Shalit; Achia Urbach
Journal:  FASEB J       Date:  2019-08-07       Impact factor: 5.191

Review 9.  National Emphysema Treatment Trial state of the art: genetics of emphysema.

Authors:  Craig P Hersh; Dawn L DeMeo; Edwin K Silverman
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

10.  Inhibition of transforming growth factor-beta signalling attenuates interleukin (IL)-18 plus IL-2-induced interstitial lung disease in mice.

Authors:  S Segawa; D Goto; Y Yoshiga; M Sugihara; T Hayashi; Y Chino; I Matsumoto; S Ito; T Sumida
Journal:  Clin Exp Immunol       Date:  2010-01-19       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.